Capricor Therapeutics Inc (CAPR)
18.58
-0.87
(-4.47%)
USD |
NASDAQ |
Nov 04, 16:00
18.75
+0.17
(+0.91%)
Pre-Market: 08:38
Capricor Therapeutics Max Drawdown (5Y): 98.77% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.77% |
| September 30, 2024 | 98.99% |
| August 31, 2024 | 98.99% |
| July 31, 2024 | 98.99% |
| June 30, 2024 | 98.99% |
| May 31, 2024 | 98.99% |
| April 30, 2024 | 98.99% |
| March 31, 2024 | 98.99% |
| February 29, 2024 | 98.99% |
| January 31, 2024 | 98.99% |
| December 31, 2023 | 98.99% |
| November 30, 2023 | 98.99% |
| October 31, 2023 | 98.99% |
| September 30, 2023 | 98.99% |
| August 31, 2023 | 98.99% |
| July 31, 2023 | 98.99% |
| June 30, 2023 | 98.99% |
| May 31, 2023 | 98.99% |
| April 30, 2023 | 98.99% |
| March 31, 2023 | 98.99% |
| February 28, 2023 | 98.99% |
| January 31, 2023 | 98.99% |
| December 31, 2022 | 98.99% |
| November 30, 2022 | 98.99% |
| October 31, 2022 | 98.99% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.99% |
| August 31, 2022 | 98.99% |
| July 31, 2022 | 98.99% |
| June 30, 2022 | 98.99% |
| May 31, 2022 | 98.99% |
| April 30, 2022 | 98.99% |
| March 31, 2022 | 98.99% |
| February 28, 2022 | 98.99% |
| January 31, 2022 | 98.99% |
| December 31, 2021 | 98.99% |
| November 30, 2021 | 98.99% |
| October 31, 2021 | 98.99% |
| September 30, 2021 | 98.99% |
| August 31, 2021 | 98.99% |
| July 31, 2021 | 98.99% |
| June 30, 2021 | 98.99% |
| May 31, 2021 | 98.99% |
| April 30, 2021 | 98.99% |
| March 31, 2021 | 98.99% |
| February 28, 2021 | 98.99% |
| January 31, 2021 | 98.99% |
| December 31, 2020 | 98.99% |
| November 30, 2020 | 98.99% |
| October 31, 2020 | 98.99% |
| September 30, 2020 | 98.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.49%
Minimum
Nov 2019
98.99%
Maximum
Dec 2019
98.97%
Average
98.99%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
| Abbott Laboratories | 33.88% |
| ResMed Inc | 53.98% |
| enVVeno Medical Corp | 97.41% |
| Regenxbio Inc | 84.15% |
| AIM ImmunoTech Inc | 99.61% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -2.944 |
| Beta (5Y) | 3.996 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 230.4% |
| Historical Sharpe Ratio (5Y) | 0.2111 |
| Historical Sortino (5Y) | 1.196 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.52% |